Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × chiauranib × Clear all

NCT05336721 2025-03-24

A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC

Phase 2 Terminated

Triple Negative Breast Neoplasms